Nectar Social | $10,600,000 | (Jun 6, 2025)
Voltrac | $2,286,772 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025)
Certified by Founder
Lodge
ArkeaBio™
start up
United States
- Charlestown, Massachusetts
- 10/05/2024
- Series A
- $26,500,000
ArkeaBioTM is an ag-biotech start-up developing a safe, user-friendly, and cost-conscious vaccine to reduce ruminant methane emissions that will work seamlessly with existing global agribusiness practices.
- Industry Biotechnology Research
- Website https://www.arkeabio.com/
- LinkedIn https://www.linkedin.com/company/arkeabio/
Related People
Colin SouthFounder
United States -
Boston, Massachusetts
Experience leading dynamic, technically intense organizations in the Food, Life Sciences, and Energy sectors. Extensive engineering and science training and experience combined with management and technology leadership roles. Experience in high-profile executive roles with world-class teams to execute high-stakes management decisions. Business focus in complex roles; defining value capture strategies, establishing pathways to commercialization and overcoming complex business obstacles.
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Aive | $13,700,350 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)